May 26, 2022 — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
May 26, 2022 — For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol ...
May 25, 2022 — Immune response and the lymphatic system are central to cardiac repair after a heart attack, according to ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
May 25, 2022 — Researchers from the group of Eva van Rooij used advanced sequencing technology to better understand the ...
May 24, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...
May 24, 2022 — The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has ...
May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...
May 23, 2022 — New findings from the Ascension Health System’s internal National Cardiovascular Data Registry (NCDR) ...
May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac ...
May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...
May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...
May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...
May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking ...
May 19, 2022 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial enrollment in ...
May 18 2022 — Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours ...